Metoprolol Succinate

GPTKB entity

Statements (45)
Predicate Object
gptkbp:instance_of gptkb:blockade
gptkbp:brand gptkb:Astra_Zeneca
gptkb:Toprol-XL
gptkbp:category gptkb:C
gptkbp:chemical_formula C15 H25 NO3
gptkbp:class selective beta-1 adrenergic antagonist
aryloxypropanolamine
gptkbp:contraindication gptkb:asthma
heart block
severe bradycardia
gptkbp:dosage_form 200 mg once daily
100 mg once daily
400 mg once daily
50 mg once daily
gptkbp:excretion urine
gptkbp:form extended-release tablet
solution for injection
gptkbp:formulation sustained-release
immediate-release
gptkbp:healthcare gptkb:1992
https://www.w3.org/2000/01/rdf-schema#label Metoprolol Succinate
gptkbp:indication anxiety
thyrotoxicosis
post-myocardial infarction
migraine prophylaxis
gptkbp:interacts_with gptkb:digoxin
MAO inhibitors
calcium channel blockers
gptkbp:lifespan 3 to 7 hours
gptkbp:metabolism liver
gptkbp:route_of_administration oral
intravenous
gptkbp:side_effect gptkb:depression
dizziness
fatigue
bradycardia
gptkbp:trade gptkb:Betaloc
gptkb:Lopressor
gptkbp:used_for hypertension
heart failure
arrhythmias
angina pectoris
gptkbp:weight 265.37 g/mol
gptkbp:bfsParent gptkb:metoprolol
gptkbp:bfsLayer 5